FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3034342514> ?p ?o ?g. }

• W3034342514 abstract "Abstract Objective To characterize long-term repopulation of peripheral immune cells following alemtuzumab-induced lymphopenia in relapsing-remitting MS (RRMS), with a focus on regulatory cell types, and to explore associations with clinical outcome measures. Methods The project was designed as a multicenter add-on longitudinal mechanistic study for RRMS patients enrolled in CARE-MS II, CARE-MS II extension at the University of Southern California and Stanford University, and an investigator-initiated study conducted at the Universities of British Columbia and Chicago. Methods involved collection of blood at baseline, prior to alemtuzumab administration, and at months 5, 11, 17, 23, 36, and 48 post-treatment. T cell, B cell, and natural killer (NK) cell subsets, chemokine receptor expression in T cells, in vitro cytokine secretion patterns, and regulatory T cell (Treg) function were assessed. Clinical outcomes, including expanded disability status score (EDSS), relapses, conventional magnetic resonance imaging (MRI) measures, and incidents of secondary autoimmunity were tracked. Results Variable shifts in lymphocyte populations occurred over time in favor of CD4+ T cells, B cells, and NK cells with surface phenotypes characteristic of regulatory subsets, accompanied by reduced ratios of effector to regulatory cell types. Evidence of increased Treg competence was observed after each treatment course. CD4+ and CD8+ T cells that express CXCR3 and CCR5 and CD8+ T cells that express CDR3 and CCR4 were also enriched after treatment, indicating heightened trafficking potential in activated T cells. Patterns of repopulation were not associated with measures of clinical efficacy or secondary autoimmunity, but exploratory analyses using a random generalized estimating equation (GEE) Poisson model provide preliminary evidence of associations between pro-inflammatory cell types and increased risk for gadolinium (Gd+) enhancing lesions, while regulatory subsets were associated with reduced risk. In addition, the risk for T2 lesions correlated with increases in CD3+CD8+CXCR3+ cells. Conclusions Lymphocyte repopulation after alemtuzumab treatment favors regulatory subsets in the T cell, B cell, and NK cell compartments. Clinical efficacy may reflect the sum of interactions among them, leading to control of potentially pathogenic effector cell types. Several immune measures were identified as possible biomarkers of lesion activity. Future studies are necessary to more precisely define regulatory and effector subsets and their contributions to clinical efficacy and risk for secondary autoimmunity in alemtuzumab-treated patients, and to reveal new insights into mechanisms of immunopathogenesis in MS. Trial registration Parent trials for this study are registered with ClinicalTrials.gov : CARE-MS II: NCT00548405 , CARE-MS II extension: NCT00930553 and ISS: NCT01307332 ." @default.
• W3034342514 created "2020-06-19" @default.
• W3034342514 creator A5000907740 @default.
• W3034342514 creator A5007747899 @default.
• W3034342514 creator A5017781416 @default.
• W3034342514 creator A5022187211 @default.
• W3034342514 creator A5027660549 @default.
• W3034342514 creator A5030980805 @default.
• W3034342514 creator A5038510055 @default.
• W3034342514 creator A5052124804 @default.
• W3034342514 creator A5055208994 @default.
• W3034342514 creator A5059117638 @default.
• W3034342514 creator A5068298197 @default.
• W3034342514 creator A5077423323 @default.
• W3034342514 creator A5087065661 @default.
• W3034342514 date "2020-06-15" @default.
• W3034342514 modified "2023-10-17" @default.
• W3034342514 title "Repopulation of T, B, and NK cells following alemtuzumab treatment in relapsing-remitting multiple sclerosis" @default.
• W3034342514 cites W1487631743 @default.
• W3034342514 cites W1523413731 @default.
• W3034342514 cites W1554919938 @default.
• W3034342514 cites W1600713671 @default.
• W3034342514 cites W1666336517 @default.
• W3034342514 cites W1896163982 @default.
• W3034342514 cites W1939683868 @default.
• W3034342514 cites W1949819251 @default.
• W3034342514 cites W1963511922 @default.
• W3034342514 cites W1963701987 @default.
• W3034342514 cites W1967973643 @default.
• W3034342514 cites W1972758773 @default.
• W3034342514 cites W1975254445 @default.
• W3034342514 cites W1981140807 @default.
• W3034342514 cites W1990840926 @default.
• W3034342514 cites W1995666459 @default.
• W3034342514 cites W2009253992 @default.
• W3034342514 cites W2010322940 @default.
• W3034342514 cites W2021538155 @default.
• W3034342514 cites W2037330887 @default.
• W3034342514 cites W2047302451 @default.
• W3034342514 cites W2053763669 @default.
• W3034342514 cites W2054539129 @default.
• W3034342514 cites W2060344378 @default.
• W3034342514 cites W2072910092 @default.
• W3034342514 cites W2080660536 @default.
• W3034342514 cites W2084177625 @default.
• W3034342514 cites W2086080135 @default.
• W3034342514 cites W2086556660 @default.
• W3034342514 cites W2089840168 @default.
• W3034342514 cites W2094875942 @default.
• W3034342514 cites W2101387120 @default.
• W3034342514 cites W2101483035 @default.
• W3034342514 cites W2104188690 @default.
• W3034342514 cites W2106190040 @default.
• W3034342514 cites W2106948231 @default.
• W3034342514 cites W2112044962 @default.
• W3034342514 cites W2113485611 @default.
• W3034342514 cites W2122347714 @default.
• W3034342514 cites W2127643620 @default.
• W3034342514 cites W2140848986 @default.
• W3034342514 cites W2148766438 @default.
• W3034342514 cites W2150747144 @default.
• W3034342514 cites W2154775026 @default.
• W3034342514 cites W2158202057 @default.
• W3034342514 cites W2163034650 @default.
• W3034342514 cites W2163410642 @default.
• W3034342514 cites W2163750459 @default.
• W3034342514 cites W2168535576 @default.
• W3034342514 cites W2204428630 @default.
• W3034342514 cites W2265012467 @default.
• W3034342514 cites W2301758340 @default.
• W3034342514 cites W2425974003 @default.
• W3034342514 cites W2470430235 @default.
• W3034342514 cites W2500212026 @default.
• W3034342514 cites W2531523188 @default.
• W3034342514 cites W2531934651 @default.
• W3034342514 cites W2563224380 @default.
• W3034342514 cites W2584413859 @default.
• W3034342514 cites W2591655768 @default.
• W3034342514 cites W2592584994 @default.
• W3034342514 cites W2621018840 @default.
• W3034342514 cites W2623932875 @default.
• W3034342514 cites W2626464574 @default.
• W3034342514 cites W2744884072 @default.
• W3034342514 cites W2746924405 @default.
• W3034342514 cites W2758497834 @default.
• W3034342514 cites W2769741379 @default.
• W3034342514 cites W2770831486 @default.
• W3034342514 cites W2774037113 @default.
• W3034342514 cites W2784130344 @default.
• W3034342514 cites W2784734333 @default.
• W3034342514 cites W2788933778 @default.
• W3034342514 cites W2791895280 @default.
• W3034342514 cites W2791992261 @default.
• W3034342514 cites W2801723726 @default.
• W3034342514 cites W2895812473 @default.
• W3034342514 cites W2897903760 @default.
• W3034342514 cites W2899312985 @default.
• W3034342514 cites W2942661391 @default.
• W3034342514 cites W2989833866 @default.
• W3034342514 cites W2996366052 @default.

• next